Omeros Again Falls Short in PhIII Trial With Drug for Knee Surgery Patients
Omeros again falls short in PhIII trial with drug for knee surgery patients
Filed under: drug treatment news 2011
In March 2011, for instance, Omeros reported disappointing results after a Phase III study missed a slate of goals for use of the therapy in patients undergoing ACL surgeries. Omeros has produced more Phase III wins with its lead drug OMS302, for which …
Read more on FierceBiotech
Standard Review for Auxilium's Drug – Analyst Blog
Filed under: drug treatment news 2011
Xiaflex, which posted global sales of $ 56.4 million in 2011, is expected to post global revenues of $ 153 – $ 163 million in 2012. Besides the Peyronie's indication, Xiaflex is being developed for additional indications like the treatment of cellulite …
Read more on NASDAQ
Top 10 Stories of 2012
Filed under: drug treatment news 2011
17, McPhee's active capacity stood at 41,005 acre feet, nearly 100,000 acre feet lower than the same time in 2011. However, water managers say a …. Colorado and Washington are the only states where the drug is now legal. With the redrawn district …
Read more on Cortez Journal
Tivozanib And AVEO: Valuation Suggests Upside Ahead Of FDA Decision
Filed under: drug treatment news 2011
More importantly in the long-run, however, the FDA has accepted AVEO's New Drug Application for tivozanib, a potential first-line treatment for Renal Cell Carcinoma ((RCC)), and set a July 28, 2013 PDUFA date for the VEGF inhibitor. Notably … Pfizer …
Read more on Seeking Alpha